ATA Guidelines Tools

Anaplastic Thyroid Cancer ATA 2021

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1441026

Contents of this Issue

Navigation

Page 16 of 27

17 Good Practice Statement 15 ➤ Patients with brain metastases may be expected to be at increased risk if operating motor vehicles or if placed in a situation in which they may jeopardize themselves or others and therefore should be appropriately counseled. (GPS) Approaches to Bone Metastases Recommendation 29 ➤ In patients with ATC with symptomatic or threatening bone metastases—but without structural compromise or threatened spinal cord compression in need of surgical remediation—the ATA recommends palliative radiotherapy. (S-L) Recommendation 30 ➤ In patients with ATC with bone metastasis causing structural compromise in a weight-bearing region or threatening spinal cord compression, the ATA recommends orthopedic fixation before initiation of palliative radiotherapy. (S-L) Recommendation 31 ➤ In patients with ATC with bone metastasis, the ATA suggests periodic intravenous bisphosphonate infusions or subcutaneous RANK ligand inhibitor. (C-L) Good Practice Statement 16 ➤ In patients on systemic therapy who develop oligo-progressive disease, local tumor-directed therapy may be considered to postpone the need to change otherwise beneficial systemic therapy. (GPS) Approaches to Other Sites of Metastases ➤ Systemic therapy as described above is the first line of treatment, but if a particular metastasis is symptomatic or has progressed despite systemic therapy, treatment may be individualized to metastatic locations, much as would be the case for other malignancies. (N) Approaches to Oligoprogressive Metastatic Disease Good Practice Statement 11 ➤ In patients on systemic therapy who develop oligo-progressive disease, local tumor-directed therapy may be considered to postpone the need to change otherwise beneficial systemic therapy. (GPS)

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Anaplastic Thyroid Cancer ATA 2021